vs

Side-by-side financial comparison of Aurinia Pharmaceuticals Inc. (AUPH) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.

Aurinia Pharmaceuticals Inc. is the larger business by last-quarter revenue ($77.1M vs $62.0M, roughly 1.2× MID PENN BANCORP INC). Aurinia Pharmaceuticals Inc. runs the higher net margin — 273.4% vs 31.4%, a 242.0% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs 28.8%). Over the past eight quarters, Aurinia Pharmaceuticals Inc.'s revenue compounded faster (23.8% CAGR vs 21.1%).

Aurinia Pharmaceuticals Inc. is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for autoimmune and kidney diseases. Its lead approved product is Lupkynis for adult active lupus nephritis treatment, with core operations in North America and European markets, focusing on nephrology and rare immunology therapeutic segments.

Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.

AUPH vs MPB — Head-to-Head

Bigger by revenue
AUPH
AUPH
1.2× larger
AUPH
$77.1M
$62.0M
MPB
Growing faster (revenue YoY)
MPB
MPB
+2.0% gap
MPB
30.8%
28.8%
AUPH
Higher net margin
AUPH
AUPH
242.0% more per $
AUPH
273.4%
31.4%
MPB
Faster 2-yr revenue CAGR
AUPH
AUPH
Annualised
AUPH
23.8%
21.1%
MPB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AUPH
AUPH
MPB
MPB
Revenue
$77.1M
$62.0M
Net Profit
$210.8M
$19.4M
Gross Margin
88.6%
Operating Margin
43.1%
43.6%
Net Margin
273.4%
31.4%
Revenue YoY
28.8%
30.8%
Net Profit YoY
14651.2%
47.0%
EPS (diluted)
$1.52
$0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUPH
AUPH
MPB
MPB
Q4 25
$77.1M
$62.0M
Q3 25
$73.5M
$61.8M
Q2 25
$70.0M
$54.3M
Q1 25
$62.5M
$47.7M
Q4 24
$59.9M
$47.4M
Q3 24
$67.8M
$45.3M
Q2 24
$57.2M
$44.1M
Q1 24
$50.3M
$42.3M
Net Profit
AUPH
AUPH
MPB
MPB
Q4 25
$210.8M
$19.4M
Q3 25
$31.6M
$18.3M
Q2 25
$21.5M
$4.8M
Q1 25
$23.3M
$13.7M
Q4 24
$1.4M
$13.2M
Q3 24
$14.3M
$12.3M
Q2 24
$722.0K
$11.8M
Q1 24
$-10.7M
$12.1M
Gross Margin
AUPH
AUPH
MPB
MPB
Q4 25
88.6%
Q3 25
88.9%
Q2 25
89.8%
Q1 25
86.3%
Q4 24
90.7%
Q3 24
91.1%
Q2 24
84.4%
Q1 24
84.6%
Operating Margin
AUPH
AUPH
MPB
MPB
Q4 25
43.1%
43.6%
Q3 25
40.5%
39.3%
Q2 25
28.7%
7.9%
Q1 25
35.0%
35.2%
Q4 24
-2.8%
34.1%
Q3 24
17.3%
32.8%
Q2 24
-2.6%
32.4%
Q1 24
-26.3%
34.8%
Net Margin
AUPH
AUPH
MPB
MPB
Q4 25
273.4%
31.4%
Q3 25
42.9%
29.6%
Q2 25
30.7%
8.8%
Q1 25
37.4%
28.8%
Q4 24
2.4%
27.9%
Q3 24
21.2%
27.1%
Q2 24
1.3%
26.7%
Q1 24
-21.4%
28.7%
EPS (diluted)
AUPH
AUPH
MPB
MPB
Q4 25
$1.52
$0.83
Q3 25
$0.23
$0.79
Q2 25
$0.16
$0.22
Q1 25
$0.16
$0.71
Q4 24
$0.00
$0.72
Q3 24
$0.10
$0.74
Q2 24
$0.01
$0.71
Q1 24
$-0.07
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUPH
AUPH
MPB
MPB
Cash + ST InvestmentsLiquidity on hand
$80.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$581.3M
$814.1M
Total Assets
$751.6M
$6.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUPH
AUPH
MPB
MPB
Q4 25
$80.2M
Q3 25
$72.9M
Q2 25
$52.9M
Q1 25
$66.1M
Q4 24
$83.4M
Q3 24
$36.6M
Q2 24
$33.3M
Q1 24
$63.9M
Stockholders' Equity
AUPH
AUPH
MPB
MPB
Q4 25
$581.3M
$814.1M
Q3 25
$365.8M
$796.3M
Q2 25
$335.3M
$775.7M
Q1 25
$350.2M
$667.9M
Q4 24
$377.5M
$655.0M
Q3 24
$388.0M
$573.1M
Q2 24
$364.6M
$559.7M
Q1 24
$359.5M
$551.0M
Total Assets
AUPH
AUPH
MPB
MPB
Q4 25
$751.6M
$6.1B
Q3 25
$527.5M
$6.3B
Q2 25
$502.6M
$6.4B
Q1 25
$504.9M
$5.5B
Q4 24
$550.6M
$5.5B
Q3 24
$549.4M
$5.5B
Q2 24
$523.5M
$5.4B
Q1 24
$516.6M
$5.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUPH
AUPH
MPB
MPB
Operating Cash FlowLast quarter
$45.7M
$80.0M
Free Cash FlowOCF − Capex
$71.8M
FCF MarginFCF / Revenue
115.8%
Capex IntensityCapex / Revenue
13.3%
Cash ConversionOCF / Net Profit
0.22×
4.12×
TTM Free Cash FlowTrailing 4 quarters
$132.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUPH
AUPH
MPB
MPB
Q4 25
$45.7M
$80.0M
Q3 25
$44.4M
$26.3M
Q2 25
$44.2M
$29.0M
Q1 25
$1.3M
$11.5M
Q4 24
$30.1M
$51.4M
Q3 24
$17.0M
$16.9M
Q2 24
$15.8M
$18.0M
Q1 24
$-18.6M
$12.4M
Free Cash Flow
AUPH
AUPH
MPB
MPB
Q4 25
$71.8M
Q3 25
$24.3M
Q2 25
$27.2M
Q1 25
$8.8M
Q4 24
$44.5M
Q3 24
$16.8M
Q2 24
$17.7M
Q1 24
$12.1M
FCF Margin
AUPH
AUPH
MPB
MPB
Q4 25
115.8%
Q3 25
39.4%
Q2 25
50.1%
Q1 25
18.4%
Q4 24
93.8%
Q3 24
37.1%
Q2 24
40.2%
Q1 24
28.5%
Capex Intensity
AUPH
AUPH
MPB
MPB
Q4 25
13.3%
Q3 25
3.1%
Q2 25
3.2%
Q1 25
5.7%
Q4 24
14.6%
Q3 24
0.0%
Q2 24
0.7%
Q1 24
0.8%
Cash Conversion
AUPH
AUPH
MPB
MPB
Q4 25
0.22×
4.12×
Q3 25
1.41×
1.44×
Q2 25
2.06×
6.08×
Q1 25
0.06×
0.84×
Q4 24
21.07×
3.88×
Q3 24
1.19×
1.37×
Q2 24
21.94×
1.53×
Q1 24
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AUPH
AUPH

Products$74.2M96%
License Collaboration And Royalty Revenue$2.9M4%

MPB
MPB

Segment breakdown not available.

Related Comparisons